FDA Drug Application (022224) for TRILIPIX by ABBVIE

Back to FDA Applications sponsored by ABBVIE

Application Number022224
Product Number001
FormCAPSULE, DELAYED RELEASE;ORAL
DosageEQ 45MG FENOFIBRIC ACID
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameTRILIPIX
Active IngredientCHOLINE FENOFIBRATE

Active IngredientCount
List of drugs with Active Ingredient CHOLINE FENOFIBRATE2


Back to FDA Applications sponsored by ABBVIE